The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions
AUTOR(ES)
Jeffrey, Stefanie S
FONTE
BioMed Central
RESUMO
Array-based comparative genomic hybridization, RNA expression profiling, and proteomic analyses are new molecular technologies used to study breast cancer. Invasive breast cancers were originally evaluated because they provided ample quantities of DNA, RNA, and protein. The application of these technologies to pre-invasive breast lesions is discussed, including methods that facilitate their implementation. Data indicate that atypical ductal hyperplasia and ductal carcinoma in situ are precursor lesions molecularly similar to adjacent invasive breast cancer. It is expected that molecular technologies will identify breast tissue at risk for the development of unfavorable subtypes of invasive breast cancer and reveal strategies for targeted chemoprevention or eradication.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=314415Documentos Relacionados
- The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions
- The diagnosis and management of pre-invasive breast disease: Problems associated with management of pre-invasive lesions
- The diagnosis and management of pre-invasive breast disease: Radiological diagnosis
- The diagnosis and management of pre-invasive breast disease: editor's reply
- The diagnosis and management of pre-invasive breast disease: The role of new diagnostic techniques